Read how the 2026 AWS Life Sciences Symposium, the Clinical Trials track brought a shift into focus that’s well underway. Six global life sciences leaders—Novartis, Merck (with BCG), Novo Nordisk, Labcorp, Eli Lilly, and Bayer—took the stage to demonstrate what AI in drug development looks like in practice across every stage of a clinical trial.